Leiden University Scholarly Publications

Your Search

Enabled Filters

  • (-) = Journal of Bone and Mineral Research

Refine Results

Resource Type

Availability

Creation Date

Show more

Author

Show more

Language

Search results

  • RSS Feed
(21 - 40 of 50)

Pages

Impact Microindentation: Consistency of Serial Measurements and Alterations in Patients With Paget's Disease of the Tibia
Safety Observations With 3 Years of Denosumab Exposure: Comparison Between Subjects Who Received Denosumab During the Randomized FREEDOM Trial and Subjects Who Crossed Over to Denosumab During the FREEDOM Extension
Outcome of Long-Term Bisphosphonate Therapy in McCune-Albright Syndrome and Polyostotic Fibrous Dysplasia
Impact microindentation: Consistency of serial measurements and alterations in patients with Paget's disease of the tibia
Ubiquitin-Specific Protease 4 Antagonizes Osteoblast Differentiation Through Dishevelled
Single-Limb Irradiation Induces Local and Systemic Bone Loss in a Murine Model
Olav Bijvoet 1928-2014 IN MEMORIAM
Sclerostin Deficiency Is Linked to Altered Bone Composition
Longitudinal Changes in BMD and Fracture Risk in Orthotopic Liver Transplant Recipients Not Using Bone-Modifying Treatment
Two-Year Results of a Randomized Placebo-Controlled Trial of Vertebroplasty for Acute Osteoporotic Vertebral Fractures
Safety and Tolerability of Odanacatib Therapy in Postmenopausal Women with Osteoporosis: Results from the Phase III Long-Term Odanacatib Fracture Trial (LOFT)
Findings from Denosumab (Prolia (R)) Post-marketing Safety Surveillance for Atypical Femoral Fracture, Osteonecrosis of the Jaw, Severe Symptomatic Hypocalcemia, and Anaphylaxis
Evaluation of Invasive Oral Procedures and Events in Women With Postmenopausal Osteoporosis Treated With Denosumab: Results From the Pivotal Phase 3 Fracture Study Extension
Microindentation in vivo captures elements of bone fragility independently of BMD
Bone Material Strength as measured by microindentation in vivo is decreased independently of BMD in patients with fractures
An in Vitro Chondrogenic Differentiation Model Using KS483 Mouse Mesenchymal Progenitor Cell Line
Odanacatib Anti-Fracture Efficacy and Safety in Postmenopausal Women with Osteoporosis. Results from the Phase III Long-Term Odanacatib Fracture Trial (LOFT)
Atypical Subtrochanteric and Diaphyseal Femoral Fractures: Second Report of a Task Force of the American Society for Bone and Mineral Research
Van Buchem disease: Clinical, biochemical, and densitometric features of patients and disease carriers
Functional characterization of GWAS loci associated with fracture risk

Pages